Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
|
|
KYTHERA BIOPHARMACEUTICALS INC (KYTH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 10/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/02/2015 |
4
| David Nathaniel E (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 10/02/2015 |
4
| Leonard Keith R (President & CEO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Gifted 66,667 shares
@ $0
Gifted 400,000 shares
@ $0
Disposed/sold 363,076 shares
@ $0
Disposed/sold 9,105 shares
@ $0
Disposed/sold 28,082 options to buy
@ $5.5, valued at
$154.5k
Disposed/sold 81,306 options to buy
@ $5.9, valued at
$479.7k
Disposed/sold 34,148 options to buy
@ $8.22, valued at
$280.7k
Disposed/sold 51,223 options to buy
@ $8.22, valued at
$421.1k
Disposed/sold 50,400 options to buy
@ $27.5, valued at
$1.4M
Disposed/sold 33,600 options to buy
@ $27.5, valued at
$924k
Disposed/sold 89,542 options to buy
@ $44.02, valued at
$3.9M
|
|
| 10/02/2015 |
4
| Klein Keith (General Counsel) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 10/02/2015 |
4
| RENTON HOLLINGS (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 18,000 options to buy
@ $34.68, valued at
$624.2k
Disposed/sold 11,591 options to buy
@ $53.26, valued at
$617.3k
|
|
| 10/02/2015 |
4
| FENTON DENNIS M (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 3,348 shares
@ $0
Disposed/sold 18,908 options to buy
@ $0.76, valued at
$14.4k
Disposed/sold 5,672 options to buy
@ $5.29, valued at
$30k
Disposed/sold 5,672 options to buy
@ $5.9, valued at
$33.5k
Disposed/sold 5,672 options to buy
@ $7.8, valued at
$44.2k
Disposed/sold 5,672 options to buy
@ $11.69, valued at
$66.3k
Disposed/sold 5,672 options to buy
@ $16, valued at
$90.8k
Disposed/sold 6,618 options to buy
@ $21.65, valued at
$143.3k
Disposed/sold 8,400 options to buy
@ $33.26, valued at
$279.4k
Disposed/sold 11,591 options to buy
@ $53.26, valued at
$617.3k
|
|
| 10/02/2015 |
4
| Sandoval Elisabeth (Chief Commerical Officer) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 575 shares
@ $0
Disposed/sold 45,588 options to buy
@ $8.2238, valued at
$374.9k
Disposed/sold 6,700 options to buy
@ $27.5, valued at
$184.3k
Disposed/sold 15,608 options to buy
@ $44.02, valued at
$687.1k
Disposed/sold 45,344 options to buy
@ $38.53, valued at
$1.7M
|
|
| 10/02/2015 |
4
| TURNER JOSEPH L (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 1,872 shares
@ $0
Disposed/sold 18,908 options to buy
@ $1.35, valued at
$25.5k
Disposed/sold 5,672 options to buy
@ $6.58, valued at
$37.3k
Disposed/sold 5,672 options to buy
@ $8.22, valued at
$46.6k
Disposed/sold 5,672 options to buy
@ $16, valued at
$90.8k
Disposed/sold 6,618 options to buy
@ $21.65, valued at
$143.3k
Disposed/sold 8,400 options to buy
@ $33.26, valued at
$279.4k
Disposed/sold 11,591 options to buy
@ $53.26, valued at
$617.3k
|
|
| 10/02/2015 |
4
| Beddingfield III Frederick (Chief Medical Officer) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 575 shares
@ $0
Disposed/sold 28,125 options to buy
@ $22.49, valued at
$632.5k
Disposed/sold 19,266 options to buy
@ $44.02, valued at
$848.1k
Disposed/sold 45,344 options to buy
@ $38.53, valued at
$1.7M
|
|
| 10/02/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 10/02/2015 |
4
| Kress Francois (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 10/02/2015 |
4
| Rich Douglas A. (Vice President Operations) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 2,044 shares
@ $0
Disposed/sold 40,000 options to buy
@ $32.61, valued at
$1.3M
Disposed/sold 28,217 options to buy
@ $38.53, valued at
$1.1M
Disposed/sold 20,000 options to buy
@ $47.63, valued at
$952.6k
|
|
| 10/02/2015 |
4
| Samuels Camille D (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 13,685 shares
@ $0
Disposed/sold 5,672 options to buy
@ $16, valued at
$90.8k
Disposed/sold 6,618 options to buy
@ $21.65, valued at
$143.3k
Disposed/sold 8,400 options to buy
@ $33.26, valued at
$279.4k
Disposed/sold 11,591 options to buy
@ $53.26, valued at
$617.3k
|
|
| 10/01/2015 |
8-K
| Quarterly results |
| 09/28/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 09/28/2015 |
4
| Beddingfield III Frederick (Chief Medical Officer) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Sold 110,638 shares
@ $74.907, valued at
$8.3M
Exercised 46,875 options
@ $22.49, valued at
$1.1M
Exercised 50,000 options
@ $22.49, valued at
$1.1M
Exercised 13,763 options
@ $44.02, valued at
$605.8k
|
|
| 09/28/2015 |
8-K
| Form 8-K - Current report |
| 09/24/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 09/24/2015 |
4
| Sandoval Elisabeth (Chief Commercial Officer) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Sold 10,590 shares
@ $74.9, valued at
$793.2k
Sold 11,892 shares
@ $74.9, valued at
$890.7k
Sold 22,690 shares
@ $74.9, valued at
$1.7M
Sold 26,800 shares
@ $74.9, valued at
$2M
Sold 11,150 shares
@ $74.9, valued at
$835.1k
Exercised 10,590 options
@ $8.22, valued at
$87k
Exercised 11,892 options
@ $8.22, valued at
$97.8k
Exercised 22,690 options
@ $8.22, valued at
$186.5k
Exercised 13,400 options
@ $27.5, valued at
$368.5k
Exercised 11,150 options
@ $44.02, valued at
$490.8k
|
|
| 09/24/2015 |
4
| Klein Keith (General Counsel) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 09/23/2015 |
4
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 09/23/2015 |
4
| Klein Keith (General Counsel) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 09/23/2015 |
4/A
| Smither John W (CFO) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC |
| 09/02/2015 |
4
| Samuels Camille D (Director) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Sold 250 shares
@ $74.718, valued at
$18.7k
|
|
| 08/21/2015 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 08/18/2015 |
8-K
| Form 8-K - Current report |
| 08/06/2015 |
4
| Sandoval Elisabeth (Chief Commercial Officer) has filed a Form 4 on KYTHERA BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,728 shares
@ $74.75, valued at
$203.9k
|
|
| 08/06/2015 |
10-Q
| Quarterly Report for the period ended June 30, 2015 |
| 08/06/2015 |
8-K
| Form 8-K - Current report |
| 08/05/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 08/05/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 08/05/2015 |
8-K
| Form 8-K - Current report |
|
|
|